Katalog der Deutschen Nationalbibliothek

Expertensuche ?

Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00

Leichte Bedienung, intuitive Suche: Die Betaversion unseres neuen Katalogs ist online! → Zur Betaversion des neuen DNB-Katalogs

24. Dezember 2025 bis 1. Januar 2026: Die Deutsche Nationalbibliothek bleibt an beiden Standorten geschlossen. Bestellte Medien werden am 2. Januar 2026 bereitgestellt. // 24 December 2025 to 1 January 2026: The German National Library will be closed at both locations. Ordered media will be made available on 2 January 2026.

Ergebnis der Suche nach: "Originator"
im Bestand: Gesamter Bestand

41 - 50 von 146

	41	Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 2—Biosimilar and Originator Etanercept in the Outpatient Setting Enthalten in BioDrugs 3.4.2019: 1-8
	42	Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment Enthalten in Journal of neurology 9.2.2019: 1-6
	43	Bettymania and the Death of Celebrity Culture Enthalten in Historical social research / Supplement 2019, Nr. 32: 139-164
	44	É possível ver imagens? (ou do porquê van Fraassen deveria rever a sua abordagem em relação a elas) Gava, Alessio. - Mannheim, 2018
	45	Incorporating historical information in biosimilar trials: Challenges and a hybrid Bayesian‐frequentist approach Enthalten in Biometrical journal Bd. 60, 2018, Nr. 3: 564-582. 19 S.
	46	Conformity and Influence Enthalten in The B.E. journal of theoretical economics Bd. 19, 2018, Nr. 1. 29 S.
	47	Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet’s disease Enthalten in Internal and emergency medicine 25.10.2018: 1-4
	48	Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study Enthalten in BioDrugs 20.10.2018: 1-11
	49	The Importance of Originator-Servicer Affiliation in Loan Renegotiation Enthalten in The journal of real estate finance and economics 31.7.2018: 1-34
	50	Comparative risk/benefit profile of biosimilar and originator erythropoiesis-stimulating agents (ESAs): data from an Italian observational study in nephrology Enthalten in European journal of clinical pharmacology 10.2.2018: 1-6